Koyfin Home > Directory > Health Care > Adamas Pharma > EV / EBITDA (ltm)

Adamas Pharma EV / EBITDA (ltm) Chart (ADMS)

Adamas Pharma annual/quarterly EV / EBITDA (ltm) from 2014 to 2015. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Adamas Pharma EV / EBITDA (ltm) for the quarter ending August 08, 2015 was 27.68 a -4.38% decrease of -1.21 year over year
  • Adamas Pharma EV / EBITDA (ltm) for the last 12 months ending August 08, 2015 was 27.68 a -4.38% decrease of -1.21 year over year
  • Adamas Pharma Annual EV / EBITDA (ltm) for 2015 was 27.68 a 0.34% increase of 0.09 from 2014
  • Adamas Pharma Annual EV / EBITDA (ltm) for 2015 was 27.58 a -0.45% decrease of -0.12 from 2014
  • Adamas Pharma Annual EV / EBITDA (ltm) for 2015 was 27.71 a -4.27% decrease of -1.18 from 2014
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS EV / EBITDA (ltm) Data

08/201527.68
08/201527.58
08/201527.71
08/201528.89
08/201529.08
08/201529.09
07/201529.12
07/201529.39
07/201530.07
07/201531.89

Annual ADMS EV / EBITDA (ltm) Data

201527.68
201527.58
201527.71
201528.89
201529.08
201529.09
201529.12
201529.39
201530.07
201531.89